The pharmacokinetics and safety of idelalisib in subjects with severe renal impairment

被引：0
|
作者：
Jin, Feng [1 ]
Robeson, Michelle [2 ]
Zhou, Huafeng [2 ]
Hisoire, Grace [1 ]
Ramanathan, Srini [1 ]
机构：
[1] Gilead Sci Inc, Foster City, CA 94404 USA
[2] Gilead Sci Inc, Seattle, WA USA
来源：
CANCER RESEARCH | 2014年 / 74卷 / 19期
关键词：
D O I：
10.1158/1538-7445.AM2014-CT204
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CT204
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Pharmacokinetics, Tolerability, and Safety of Murepavadin, a Novel Antipseudomonal Antibiotic, in Subjects with Mild, Moderate, or Severe Renal Function Impairment
    Dale, Glenn E.
    Halabi, Atef
    Petersen-Sylla, Marc
    Wach, Achim
    Zwingelstein, Christian
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (09)
  • [32] Pharmacokinetics of Teneligliptin in Subjects With Renal Impairment
    Halabi, Atef
    Maatouk, Haidar
    Siegler, Karl Ernst
    Faisst, Nadja
    Lufft, Volkmar
    Klause, Norbert
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2013, 2 (03): : 246 - 254
  • [33] Garenoxacin pharmacokinetics in subjects with renal impairment
    Krishna, Gopal
    Gajjar, Diptee
    Swan, Suzanne
    Marbury, Thomas
    Grasela, Dennis M.
    Wang, Zaiqi
    CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 (03) : 649 - 657
  • [34] Pharmacokinetics of repaglinide in subjects with renal impairment
    Marbury, TC
    Ruckle, JL
    Hatorp, V
    Andersen, MP
    Nielsen, KK
    Huang, WC
    Strange, P
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 67 (01) : 7 - 15
  • [35] Pharmacokinetics of teduglutide in subjects with renal impairment
    Nave, Ruediger
    Halabi, Atef
    Herzog, Rolf
    Schaffer, Peter
    Diefenbach, Joerg
    Krause, Stephan
    Berghoefer, Peter
    Lahu, Gezim
    Hartmann, Manfred
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 69 (05) : 1149 - 1155
  • [36] Pharmacokinetics of teduglutide in subjects with renal impairment
    Rüdiger Nave
    Atef Halabi
    Rolf Herzog
    Peter Schaffer
    Jörg Diefenbach
    Stephan Krause
    Peter Berghöfer
    Gezim Lahu
    Manfred Hartmann
    European Journal of Clinical Pharmacology, 2013, 69 : 1149 - 1155
  • [37] Effect of Severe Renal Impairment on the Safety, Tolerability, and Pharmacokinetics of AMG 986
    Trivedi, Ashit
    Mather, Omar
    Vega, Silvia
    Simiens, Mary Ann
    Hellawell, Jennifer
    Lee, Edward
    DRUGS IN R&D, 2022, 22 (01) : 89 - 94
  • [38] Effect of Severe Renal Impairment on the Safety, Tolerability, and Pharmacokinetics of AMG 986
    Ashit Trivedi
    Omar Mather
    Silvia Vega
    Mary Ann Simiens
    Jennifer Hellawell
    Edward Lee
    Drugs in R&D, 2022, 22 : 89 - 94
  • [39] Pharmacokinetics of elbasvir and grazoprevir in subjects with end-stage renal disease or severe renal impairment
    Caro, Luzelena
    Wenning, Larissa
    Feng, Hwa-Ping
    Guo, Zifang
    Du, Lihong
    Bhagunde, Pratik
    Fandozzi, Christine
    Panebianco, Deborah
    Marshall, William L.
    Butterton, Joan R.
    Iwamoto, Marian
    Yeh, Wendy W.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 75 (05) : 665 - 675
  • [40] Pharmacokinetics of elbasvir and grazoprevir in subjects with end-stage renal disease or severe renal impairment
    Luzelena Caro
    Larissa Wenning
    Hwa-Ping Feng
    Zifang Guo
    Lihong Du
    Pratik Bhagunde
    Christine Fandozzi
    Deborah Panebianco
    William L. Marshall
    Joan R. Butterton
    Marian Iwamoto
    Wendy W. Yeh
    European Journal of Clinical Pharmacology, 2019, 75 : 665 - 675
12345